Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 3242143, 6 pages
http://dx.doi.org/10.1155/2016/3242143
Clinical Study

No Significant Reduction of Circulating Endothelial-Derived and Platelet-Derived Microparticles in Patients with Psoriasis Successfully Treated with Anti-IL12/23

Department of Dermatology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Ta-Pei Road 123, Niao-Sung, Kaohsiung 83301, Taiwan

Received 21 January 2016; Revised 17 March 2016; Accepted 20 March 2016

Academic Editor: Enrico Compalati

Copyright © 2016 Ji-Chen Ho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Gelfand, E. D. Dommasch, D. B. Shin et al., “The risk of stroke in patients with psoriasis,” Journal of Investigative Dermatology, vol. 129, no. 10, pp. 2411–2418, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. N. N. Mehta, R. S. Azfar, D. B. Shin, A. L. Neimann, A. B. Troxel, and J. M. Gelfand, “Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database,” European Heart Journal, vol. 31, no. 8, pp. 1000–1006, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. N. N. Mehta, R. Pinnelas, P. Krishnamoorthy et al., “Attributable risk estimate of severe psoriasis on major cardiovascular events,” The American Journal of Medicine, vol. 124, no. 8, pp. 775.e1–775.e6, 2011. View at Google Scholar
  4. N. Kurtzman, L. Zhang, B. French et al., “Personalized cytomic assessment of vascular health: evaluation of the vascular health profile in diabetes mellitus,” Cytometry Part B—Clinical Cytometry, vol. 84, no. 4, pp. 255–266, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. J. H. W. Distler, C. Beyer, G. Schett, T. F. Lüscher, S. Gay, and O. Distler, “Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases,” Arthritis and Rheumatism, vol. 60, no. 11, pp. 3168–3179, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Beyer and D. S. Pisetsky, “The role of microparticles in the pathogenesis of rheumatic diseases,” Nature Reviews Rheumatology, vol. 6, no. 1, pp. 21–29, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Pelletier, F. Garnache-Ottou, F. Angelot et al., “Increased levels of circulating endothelial-derived microparticles and small-size platelet-derived microparticles in psoriasis,” Journal of Investigative Dermatology, vol. 131, no. 7, pp. 1573–1576, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Tamagawa-Mineoka, N. Katoh, and S. Kishimoto, “Platelet activation in patients with psoriasis: increased plasma levels of platelet-derived microparticles and soluble P-selectin,” Journal of the American Academy of Dermatology, vol. 62, no. 4, pp. 621–626, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Martínez-Sales, V. Vila, J. M. Ricart et al., “Increased circulating endothelial cells and microparticles in patients with psoriasis,” Clinical Hemorheology and Microcirculation, vol. 60, no. 3, pp. 283–290, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Takeshita, E. R. Mohler, P. Krishnamoorthy et al., “Endothelial cell-, platelet-, and monocyte/macrophage-derived microparticles are elevated in psoriasis beyond cardiometabolic risk factors,” Journal of the American Heart Association, vol. 3, no. 1, Article ID e000507, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Pirro, L. Stingeni, G. Vaudo et al., “Systemic inflammation and imbalance between endothelial injury and repair in patients with psoriasis are associated with preclinical atherosclerosis,” European Journal of Preventive Cardiology, vol. 22, no. 8, pp. 1027–1035, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Pelletier, F. Garnache-Ottou, S. Biichlé et al., “Effects of anti-TNF-α agents on circulating endothelial-derived and platelet-derived microparticles in psoriasis,” Experimental Dermatology, vol. 23, no. 12, pp. 924–925, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Reich, R. G. Langley, M. Lebwohl et al., “Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies,” British Journal of Dermatology, vol. 164, no. 4, pp. 862–872, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Hugh, A. S. Van Voorhees, R. I. Nijhawan et al., “From the Medical Board of the National Psoriasis Foundation: the risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies,” Journal of the American Academy of Dermatology, vol. 70, no. 1, pp. 168–177, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. H.-M. Lakka, D. E. Laaksonen, T. A. Lakka et al., “The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men,” Journal of the American Medical Association, vol. 288, no. 21, pp. 2709–2716, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Pirro, G. Schillaci, F. Bagaglia et al., “Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk,” Atherosclerosis, vol. 197, no. 2, pp. 757–767, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. O. Morel, F. Toti, B. Hugel et al., “Procoagulant microparticles: disrupting the vascular homeostasis equation?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 12, pp. 2594–2604, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. C. M. Boulanger, A. Scoazec, T. Ebrahimian et al., “Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction,” Circulation, vol. 104, no. 22, pp. 2649–2652, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Shantsila, P. W. Kamphuisen, and G. Y. H. Lip, “Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis,” Journal of Thrombosis and Haemostasis, vol. 8, no. 11, pp. 2358–2368, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. S. Leroyer, F. Anfosso, R. Lacroix et al., “Endothelial-derived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis,” Thrombosis and Haemostasis, vol. 104, no. 3, pp. 456–463, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. W. A. Muller, S. A. Weigl, X. Deng, and D. M. Phillips, “PECAM-1 is required for transendothelial migration of leukocytes,” Journal of Experimental Medicine, vol. 178, no. 2, pp. 449–460, 1993. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Ríos-Navarro, C. de Pablo, V. Collado-Diaz et al., “Differential effects of anti-TNF-α and anti-IL-12/23 agents on human leukocyte-endothelial cell interactions,” European Journal of Pharmacology, vol. 765, pp. 355–365, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Combes, A.-C. Simon, G.-E. Grau et al., “In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant,” The Journal of Clinical Investigation, vol. 104, no. 1, pp. 93–102, 1999. View at Publisher · View at Google Scholar · View at Scopus